News Covis finally pulls preterm birth drug Makena from market Following FDA recommendation for withdrawal, Covid finally pulls premature birth drug Makena.
Views & Analysis COVID-19 and premature babies: Locking down to protect their... Everyone is living with a certain degree of COVID-19-related fear and anxiety at the moment – but spare a thought for the parents of premature and sick babies.
News UK MHRA green lights AbbVie’s ELAHERE for ovarian cancer AbbVie has secured UK marketing authorisation for ELAHERE (mirvetuximab soravtansine), the first antibo
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
